TEAD4-CD82 Fusion FISH Probe
The TEAD4-CD82 Fusion FISH Probe is used to confirm a fusion of the TEAD4 and CD82 genes. The fusion of the TEAD4 and CD82 genes has been associated with Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TEAD4-CD82-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TEAD4-CD82-20-AQAQ | 20 (40 μL) | 200 μL |
|
CD82 Gene Summary
This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression of human cancers and can be activated by p53 through a consensus binding sequence in the promoter. Its expression and that of p53 are strongly correlated, and the loss of expression of these two proteins is associated with poor survival for prostate cancer patients. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Gene Name: CD82 Molecule
Chromosome: CHR11: 44587140 -44641315
Locus: 11p11.2
TEAD4 Gene Summary
This gene product is a member of the transcriptional enhancer factor (TEF) family of transcription factors, which contain the TEA/ATTS DNA-binding domain. It is preferentially expressed in the skeletal muscle, and binds to the M-CAT regulatory element found in promoters of muscle-specific genes to direct their gene expression. Alternatively spliced transcripts encoding distinct isoforms, some of which are translated through the use of a non-AUG (UUG) initiation codon, have been described for this gene. [provided by RefSeq, Jul 2008]
Gene Name: TEA Domain Transcription Factor 4
Chromosome: CHR12: 3068477 -3149842
Locus: 12p13.33
Gene Diseases
The TEAD4 CD82 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|